Number of responders to polyribosylribitol phosphate (PRP) antigen Post-dose 3 (Month 7) [clinicaltrials_resource:634c101677850d770faf386120831d56]
V419 + DAPTACEL™ + PedvaxHIB™ + Prevnar 13™ + RotaTeq™
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Number of responders to polyribosylribitol phosphate (PRP) antigen Post-dose 3 (Month 7) [clinicaltrials_resource:634c101677850d770faf386120831d56]
V419 + DAPTACEL™ + PedvaxHIB™ + Prevnar 13™ + RotaTeq™
Bio2RDF identifier
634c101677850d770faf386120831d56
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:634c101677850d770faf386120831d56
measure [clinicaltrials_vocabulary:measure]
Number of responders to polyribosylribitol phosphate (PRP) antigen
time frame [clinicaltrials_vocabulary:time-frame]
Post-dose 3 (Month 7)
description
V419 + DAPTACEL™ + PedvaxHIB™ + Prevnar 13™ + RotaTeq™
identifier
clinicaltrials_resource:634c101677850d770faf386120831d56
title
Number of responders to polyribosylribitol phosphate (PRP) antigen Post-dose 3 (Month 7)
@en
type
label
Number of responders to polyri ...... c101677850d770faf386120831d56]
@en